Open AccessCurrent Insights on the Treatment of Anaplastic Lymphoma Kinase-Positive Metastatic Non-Small Cell Lung Cancer: Focus on Brigatinib
Author(s) -
Erika Rijavec,
Federica Biello,
Alice Indini,
Francesco Grossi,
Carlo Genova
Publication year - 2022
Publication title -
clinical pharmacology advances and applications
Language(s) - English
Resource type - Journals
ISSN - 1179-1438
DOI - 10.2147/cpaa.s284850
Subject(s) - crizotinib , anaplastic lymphoma kinase , medicine , alk inhibitor , lung cancer , tyrosine kinase inhibitor , oncology , clinical trial , tyrosine kinase , lymphoma , cancer , cancer research , receptor , malignant pleural effusion
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom